{"id":196441,"date":"2026-08-12T20:21:25","date_gmt":"2026-08-12T12:21:25","guid":{"rendered":"https:\/\/www.chinamoneynetwork.com\/?p=159513"},"modified":"2026-08-12T20:21:25","modified_gmt":"2026-08-12T12:21:25","slug":"beyang-therapeutics-secures-30-million-in-series-a-financing-for-drug-rd","status":"publish","type":"post","link":"https:\/\/www.chinalegalblog.com\/en\/2026\/08\/12\/beyang-therapeutics-secures-30-million-in-series-a-financing-for-drug-rd\/","title":{"rendered":"Beyang Therapeutics Secures $30 Million in Series A Financing for Drug R&amp;D"},"content":{"rendered":"Beyang Therapeutics Co., Ltd. has successfully closed an oversubscribed Series A financing round, raising nearly $30 million to advance global...","protected":false},"excerpt":{"rendered":"<p>Beyang Therapeutics Co., Ltd. has successfully closed an oversubscribed Series A financing round, raising nearly $30 million to advance global&#8230;<\/p>\n","protected":false},"author":252,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[477,288,194,494,401,1542,1623],"tags":[11682,13685,11015,13686,5256,10733,4793],"class_list":["post-196441","post","type-post","status-publish","format-standard","hentry","category-investment","category-medicine","category-news-chinese-law","category-pharmaceutical","category-shanghai","category-technology","category-venture-capital","tag-ai-drug-discovery","tag-beyang-therapeutics","tag-clinical-development","tag-drug-rd","tag-healthcare","tag-industry","tag-series-a-financing"],"_links":{"self":[{"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/posts\/196441","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/users\/252"}],"replies":[{"embeddable":true,"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/comments?post=196441"}],"version-history":[{"count":1,"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/posts\/196441\/revisions"}],"predecessor-version":[{"id":196442,"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/posts\/196441\/revisions\/196442"}],"wp:attachment":[{"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/media?parent=196441"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/categories?post=196441"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/tags?post=196441"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}